v3.26.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)
12 Months Ended
Dec. 31, 2025
USD ($)
Integer
Dec. 31, 2024
USD ($)
Product Information [Line Items]    
Number of operating segments | Integer 1  
Number of reportable segment | Integer 1  
Cash equivalents $ 0  
Accounts receivable 72,191,994 $ 32,639,242
Cash in excess of federally insured limits $ 1,427,627 686,177
Estimated useful life 3 to 10 years  
Goodwill $ 4,487,637 0
Revenues 82,028,176 58,384,552
Breakage Revenue [Member]    
Product Information [Line Items]    
Revenues 474,709 242,355
Settlement Revenue [Member]    
Product Information [Line Items]    
Revenues $ 0 $ 30,000
Intangible Assets [Member]    
Product Information [Line Items]    
Intangible asset useful life 3 to 15 years  
Contract Assets [Member]    
Product Information [Line Items]    
Intangible asset useful life three to five years  
Hosting Implementation [Member]    
Product Information [Line Items]    
Intangible asset useful life three year  
Accounts Receivable [Member] | Customer Concentration Risk [Member] | One Pharma Program Customer [Member]    
Product Information [Line Items]    
Concentration risk, percentage 31.00% 17.00%
Accounts Receivable [Member] | Customer Concentration Risk [Member] | Second Pharma Program Customer [Member]    
Product Information [Line Items]    
Concentration risk, percentage   15.00%
Reimbursement Receivables [Member]    
Product Information [Line Items]    
Accounts receivable $ 62,366,232 $ 27,566,694